Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Medium-wave-sensitive opsin 1 (OPN1MW) is a member of the opsin family of G protein-coupled receptors, functioning as the photopigment in retinal cone cells responsible for detecting green/yellow light (middle of the visible spectrum)[1][2][4][6]. It is located on the X chromosome and is essential for normal color vision, enabling signal transmission from cone cells to the brain for the perception of color[1][2][6]. Mutations or structural rearrangements of the OPN1MW gene lead to several hereditary vision disorders—including the common deutan type of red-green color vision deficiency and rare forms such as cone dystrophy 5 (X-linked) and blue cone monochromacy[1][2][4]. The protein consists of seven transmembrane domains typical of GPCRs, binding covalently to a cis-retinal chromophore [2][3][6]. OPN1MW is not a current target for approved pharmacological interventions, but genetic tests can identify relevant mutations for clinical and diagnostic purposes[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Medium-wave-sensitive opsin 1 (OPN1MW).